Circulation Journal Official Journal of the Japanese Circulation Society http://www. j-circ.or.jp ercutaneous coronary intervention (PCI) with stents is widely performed to treat patients with coronary artery disease (CAD), 1-7 because stenting prevents elastic recoil and residual arterial dissection, resulting in improved patency after PCI.
ISHII H et al. Values are mean ± SD where appropriate. BMS, bare metal stent; DES, drug-eluting stent; HD, hemodialysis; MI, myocardial infarction; ARB, A-II receptor blockers; ACEI, angiotensin-converting enzyme inhibitor. TM , Boston Scientific, Natick, MA, USA) has also been used. Although the physicians determined the method and device for PCI, after their introduction onto the market, a DES was implanted if patients had no contraindications and/or there was no planned surgery. Dual antiplatelet therapy [aspirin (162 mg/day) and ticlopidine (200 mg/day) or clopidogrel (75 mg/day)] was recommended for at least 2 weeks prior to PCI after checking tolerance of those drugs and followed up for at least 3 months and 1 year after BMS implantation and DES implantation, respectively.
Endpoints
We collected data on cardiovascular death, all-cause death, nonfatal myocardial infarction (MI), stent thrombosis, and clinically driven target lesion revascularization (TLR). Major adverse cardiac events (MACE) after the PCI procedure were defined as a composite endpoint of cardiovascular death, nonfatal MI, stent thrombosis, and TLR. Clinical follow-up data were obtained from hospital charts and telephone interviews with patients conducted by trained reviewers. Cardiovascular death included death from congestive heart failure, fatal MI, documented arrhythmia, stroke, and other vascular disease. In the present study, cases of sudden death and unwitnessed death were included as instances of cardiovascular death. The diagnosis of MI was base on ST-segment changes in at least 2 contiguous ECG leads, and creatine kinase elevation to more than twice the maximum peak in the normal range. Definite and probable cases according to the Academic Research Consortium definitions were considered as stent thrombosis. 17 TLR was defined as revascularization not only inside the stent but also within 5-mm borders proximal or distal to the stent segment of the initial procedure.
We performed quantitative coronary angiography (QCA) using a contour detection minimum cost algorithm (QCA-CMS Version 3.0, MEDIS, Leiden, The Netherlands). Reference vessel diameter, minimum luminal diameter, and percent diameter stenosis (%DS) were evaluated in images before and after PCI. Lesion length was also measured before PCI from QCA measurements. Coronary lesion types were characterized according to the American Heart Association/American College of Cardiology (AHA/ACC) classification. 18 A previous MI was diagnosed when an abnormal Q wave was present on the ECG or if the patient had an established history of hospitalization for a MI before PCI. Diabetes was diagnosed if the patient had a previous or current diagnosis of diabetes or if abnormal results from the oral glucose tolerance test or HbA1c levels ≥6.5% were found after admission for PCI. Serum albumin and C-reactive protein levels were measured in the morning of the day of PCI. Left ventricular ejection fraction was measured using modified Simpson's method by ultrasonic echocardiography. 19 
Statistical Analysis
The event-free survival rates for each endpoint were examined with the Kaplan-Meier method. The differences in survival rates between the BMS and DES groups were compared using the log-rank test. We used Cox proportional hazards models to assess univariate and multivariable covariates associated with progression of all patients to the endpoints. Hazard ratios (HR) and confidence intervals (CI) were calculated for each factor by Cox proportional hazards analysis, and prognostic factors to predict endpoints were determined. All prognostic valuables with P<0.05 were entered into a Cox multivariate analysis in order to determine independent predictors. Differences were considered significant at P<0.05. 
Results
Baseline Characteristics BMS were implanted in 204 patients with 266 lesions. DES were implanted in 301 patients with 362 lesions. After the introduction of DES, BMS were implanted in only 53 patients with 69 lesions.
The baseline clinical and lesion characteristics are shown in Table 1 . There was no significant difference between the BMS and DES groups, and except for stent diameter, lesion and procedural characteristics were also comparable between the 2 groups ( vs. 36.7%, P=0.88, respectively). By Kaplan-Meier analysis, the rates of MACE for 6 years were significantly higher in the BMS group than in the DES group (58.0% vs. 42.5%, P=0.036) (Figure 1) . Kaplan-Meier analysis for TLR is shown in Figure 2 . There were no significant differences in the TLR rates between patients treated with BMS (21.3%) and those with DES (17.8%) within 1 year after PCI (HR 0.81, 95%CI 0.53-1.23, P=0.32). However, interestingly, patients treated with DES (16.4%) had significantly lower rates for late TLR compared with those treated with BMS (30.9%) beyond 1 year up to 6 years after PCI (HR 0.54, 95%CI 0.32-0.91, P=0.019). In the multivariate model, serum albumin and C-reactive protein levels significantly predicted all of MACE, cardiovascular death, all-cause death and TLR ( Table 3) . Although DES was not an independent predictor of MACE, cardiovascular death, and all-cause death, it was significantly associated with prevention of TLR.
During follow-up, 7 patients in the BMS group and 4 in the DES group experienced stent thrombosis (P=0.11) ( Table 4) . Except for 1 patient in the BMS group with late thrombosis, dual antiplatelet therapy was administered to patients with stent thrombosis.
Among the patients in the DES group, 3-year rates of TLR were comparable between those treated with SES and those with paclitaxel-eluting stent (27.8% vs. 25.2%, P=0.73).
Discussion
In the present study, we demonstrated that DES might be beneficial for preventing TLR beyond 1 year after primary PCI in patients on HD. Until now, there have been limited studies investigating the long-term outcomes of such patients after PCI with DES implantation. Therefore, our report might have great significance.
It has been previously reported that among HD patients with significant coronary stenosis the event-free rates for cardiac and all-cause deaths were significantly lower in the group with PCI treatment than in the group with medication therapy only. 20 Furthermore, a survival advantage for PCI over no revascularization has been reported. 21 In the BMS era, HD patients after coronary artery bypass surgery had a better long survival rate than those after PCI with stent implantation. 11 In this study, we found that DES significantly prevented TLR for a relatively longer follow-up period than did BMS. We failed to show beneficial effects on an improvement of mortality, because of the limited number of enrolled patients, but preventing restenosis possibly improves clinical outcome because restenosis after PCI is associated with an increased risk of postoperative death. 22 From this point of the view, a prospective study comparing PCI and coronary artery bypass grafting is warranted in the near future. Kimura et al reported that freedom from TLR reached a plateau over 1-8 years after primary PCI with BMS and that late revascularization procedures are sometimes needed for progressive coronary lesions at non-target sites. 3 Also, Cutlip et al reported that the annual hazard rate for TLR was only 1.7% during years 2 through 5 after BMS implantation. 4 These data suggest that coronary lesions even after treatment with BMS implantation have stabilized if restenosis is not seen within the early phase. However, limited numbers of patients on HD were recruited into previous studies, and it is well known that in BMS era higher restenosis rates have been observed in patients on HD compared with those without HD. 23, 24 DES, on the other hand, significantly reduce the risk of restenosis after PCI in many cases, so they have been widely used in PCI for patients on HD. Unfortunately, studies have shown that the angiographic restenosis rates during a short to 3-year follow-up period have still been high when treated with SES. 12,14-16 Compared with previous studies, our present study had a larger number of enrolled patients and provided information over a longer duration. Interestingly, TLR was significantly prevented beyond 1 year after DES implantation. Recent studies have reported that late complications, such as very-late stent thrombosis and late catch-up phenomenon, after DES implantation are frequently seen. 25, 26 Contrary to such studies, our results revealed that the late catch-up phenomenon was less frequently seen in patients treated with DES compared with those with BMS. In other word, clinical stability of the stented site for a longer duration was more frequently seen after DES implantation in HD patients.
In this study, serum CRP and serum protein levels were independent predictors of MACE. It is well known that there are strong relationships among malnutrition, inflammation, and atherosclerosis in patients with chronic renal failure. 27, 28 Restenosis after PCI with either BMS or DES is frequently seen in patients with higher serum CRP levels. 29-31 Inflammatory processes are thought to progress atherosclerosis. 32-34
Study Limitations
First, the study had a single-center design with a limited number of enrolled patients. Furthermore, the short duration and low rate of follow-up in the DES group as compared with the BMS group influence the comparison of time to event analysis. In other words, the time-related lag bias and treatment selection bias were not small. Second, all patients were Japanese. A report showed 42-month survival rates in HD patients treated with BMS of 29.4% in the US. 11 The racial prognostic difference should be considered when interpreting our results. Third, we had no data on patients with left main trunk lesion and/or 3-vessel disease. In such cases, coronary artery bypass grafting is recommended in our institution and was performed 
Conclusions
In conclusion, DES might be effective for preventing TLR in the medium-term period after PCI in HD patients, although restenosis after PCI with DES was common in the short term.
